Fibroblast growth factor-23 and risks of cardiovascular and non-cardiovascular diseases: a meta-analysis
<p>Background: Fibroblast growth factor-23 (FGF23) has been associated with an increased risk of cardiovascular disease, but it is uncertain how associations for different types of cardiovascular disease vary by level of kidney function. </p><p>Methods: We identified pros...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
American Society of Nephrology
2018
|